F 0552 Review of the Medicare 5 day MDS assessment dated [DATE REDACTED] revealed a BIMS score of 14 which indicated that Resident #36 was cognitively intact. The MDS also indicated that Resident #3 was prescribed a/an: Level of Harm - Minimal harm or antipsychotic, antidepressant, opioid, antiplatelet, hypoglycemic, and anticonvulsant. potential for actual harm
Review of the May 2025 MAR revealed that Resident #36 received Seroquel for the treatment of Residents Affected - Some schizoaffective disorder, Sertraline for the treatment of bipolar disorder, Depakote for the treatment of schizoaffective disorder, Clonazepam for the treatment of generalized anxiety disorder, and Geodon for the treatment of mood.
Review of the medical record revealed that there was no consent by Resident #36 for the psychotropic medications.
On 05/21/2025 at 12:06 p.m., S7Regional Director of Clinical confirmed that there was no consent for the psychotropic medications: Seroquel, Sertraline, Depakote, Clonazepam, and Geodon.
FORM CMS-2567 (02/99) Event ID: Facility ID: If continuation sheet Previous Versions Obsolete Page 3 of 39 195585 Department of Health & Human Services Printed: 08/26/2025 Form Approved OMB Centers for Medicare & Medicaid Services No. 0938-0391
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A. Building 195585 B. Wing 05/21/2025
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
Cypress at Lake Providence 5976 US-65 North Lake Providence, LA 71254
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)